|
Catalog Number TF-23A |
Device Problem
Material Split, Cut or Torn (4008)
|
Patient Problems
Dyspnea (1816); Heart Failure/Congestive Heart Failure (4446); Aortic Valve Insufficiency/ Regurgitation (4450)
|
Event Date 05/27/2015 |
Event Type
Injury
|
Manufacturer Narrative
|
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
|
|
Event Description
|
It was reported that on (b)(4) 2015, a 23mm trifecta valve was implanted in a patient.Beginning in late february or early march of 2021, the patient began experiencing shortness of breath when going on walks.The patient also developed a cough and profuse sweating.The coughing fits were so severe at times that the patient tore a muscle in his side.Initially, physician thought that the patient had pneumonia which they treated with codeine cough syrup medication that increases the risk of cardiac events, including death.Fortunately, a pulmonologist determined that the patient symptoms were due to heart failure.More specifically, on may 13, 2021, the patient pulmonologist identified "moderate to severe aortic regurgitation." on may 26,2021, the defective trifecta heart valve was removed and replaced with a non-abbott device the patient.
|
|
Manufacturer Narrative
|
An event of a patient experiencing shortness of breath, a cough and profuse sweating was reported.It was determined that the patient's symptoms were due to heart failure, more specifically moderate to severe aortic regurgitation and a valve that was torn at the posts.A more comprehensive assessment, including histopathological examination of the valve tissue could not be performed as the device was not returned for analysis.However, based on the information received, the reported tears are consistent with structural valve deterioration (svd), specifically non-calcific leaflet tear, which is a well-known complication of tissue heart valve replacement surgery.A variety of factors may contribute to svd, including patient, biological, and implant related factors: no implant related factors could be confirmed from the information received from the field as information related to implant procedure was not provided.Biological factors which can result in tissue degeneration such as calcification (from patient conditions predisposing to elevated calcium like renal disease etc.) or thinning of the prosthetic leaflet tissue (predisposing to leaflet tears) also could not be confirmed as the valve was not returned for histopathological examination.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed, and the product met all defined manufacturing specifications.Based on the information received, the cause of the reported incident could not be conclusively determined.
|
|
Search Alerts/Recalls
|
|
|